Antiverse
PrivateLast Round
Series A
Mar 3, 2026
Total Funding Raised
$18.93M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Antiverse is a biotechnology company that develops an AI-driven platform for the design and discovery of antibody therapeutics against challenging drug targets such as G-protein coupled receptors and ion channels.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Antiverse Comparables
Compare Antiverse with similar companies based on industry and business-model similarity.
Antiverse Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 3, 2026 | ||||
| Seed | Oct 15, 2024 | ||||
| Seed | Mar 1, 2023 | ||||
| Seed | Mar 15, 2021 | ||||
| Grant | Jul 1, 2018 |
Key People
Founding team and executive leadership
Antiverse Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Future Planet Capital Regional | Seed |
| Deep Science Ventures | Seed |
| Cambridge Angels | Seed |
| Soulmates Ventures | Series A |
| Accelerate@Babraham | Grant |
| AngelHub | Seed |
| UK Innovation & Science Seed Fund | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Added Tensor, an investment firm, as a customer.
- Apr 1, 2026
Added Innosparkventures as a customer.
Antiverse Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Antiverse's valuation, stock price, and market status.